Trial Profile
Evaluation Of Use of Belimumab in Clinical Practice SEttings (OBSErve)
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Acronyms OBSErve
- Sponsors GlaxoSmithKline
- 01 Feb 2017 New trial record